Andreas Harstrick
Amministratore Delegato presso AFFIMED N.V.
Patrimonio netto: 330 783 $ in data 31/05/2024
Profilo
Andreas Harstrick is currently the Chief Executive & Medical Officer at Affimed NV.
He previously worked as a Director at Lilly Oncology.
From 2008 to 2014, he was the Senior Vice President-Medical Sciences at ImClone LLC.
He also served as the Chief Medical Officer at Molecular Partners AG from 2015 to 2019.
Prior to that, he held the position of SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd.
from 1998 to 2008.
Dr. Harstrick's education includes a doctorate degree from the University of Hannover in 1986.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AFFIMED N.V.
0.50% | 15/03/2024 | 76 042 ( 0.50% ) | 330 783 $ | 31/05/2024 |
Posizioni attive di Andreas Harstrick
| Società | Posizione | Inizio |
|---|---|---|
| AFFIMED N.V. | Amministratore Delegato | 15/01/2024 |
Precedenti posizioni note di Andreas Harstrick
| Società | Posizione | Fine |
|---|---|---|
| MOLECULAR PARTNERS AG | Direttore Tecnico/Scientifico/R&S | 01/09/2019 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2014 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | 01/01/2008 |
| University of Duisburg-Essen | Corporate Officer/Principal | - |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Direttore/Membro del Consiglio | - |
Formazione di Andreas Harstrick
| University of Hannover | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| AFFIMED N.V. | Health Technology |
| Aziende private | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Health Services |
- Borsa valori
- Insiders
- Andreas Harstrick
